Distribution of extended spectrum β-lactamase producing strains and their antibiotics resistance

耿燕,刘原,张王刚,王香玲,李淑琴,张毅
DOI: https://doi.org/10.3321/j.issn:1000-2790.2003.13.032
2003-01-01
Abstract:AIM: To study the distribution of extended spectrum β lactamase (ESBL) producing strains and their antibiotics resistance. METHODS: Automatic microbial system (Vitek) was employed for the identification of Enterobacteriaceae, disk diffusion confirmatory test for the detection of ESBL and K B disk diffusion (in accordance with the NCCLS standards) for drug susceptibility test. Clinical cases were investigated retrospectively. RESULTS: Of the 1212 strains isolated from 5 clinical laboratories, 192 (15.8%) were designated ESBL producing bacteria in Enterbacteriaceae. The positive rates of ESBL of E. coli , and K. pneu were 17.8% and 30.9% respectively. E. coli accounted for 43.8% of the bacteria, followed by K. pneu (36.0%) and E. cloa (8.3%). The most common sources of ESBL producing strains were respiratory tract (20.9%), urinary tract (16.3%) and wound secretion (15.1%). The rate of antibiotics resistance to Imipenem and cefosperazone/Sulbactam were 4.6% and 7.6% respectively. The difference of drug resistant rates between ESBL positive strains and ESBL negative strains was significant. CONCLUSION : E. coli and K. pneu are the two most common bacteria producing ESBL, the most common infection sites being respiratory tract and urinary tract. ESBL producing strains are more resistant to β lactamase antibiotics than ESBL negative strains. The best antibiotics for the treatment of ESBLs positive strains are Imipenem and cefosperazone/Sulbactam. It is suggested that the detection of ESBLs strains is of practical value in the rational use of antibiotics.
What problem does this paper attempt to address?